Long-term integrated safety of patisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy

28 August 2020 (08:00 - 18:00)
Organised by:
Congress Presentation Part of: Myocardial Disease ePosters Infiltrative Myocardial Disease ESC Premium Access ESC Congress 2020